Evidence map›Paper›PMID 35840577›Full record

ArticleNature communications2022

Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.

Mahmoud A Bassal, Saumya E Samaraweera, Kelly Lim, Brooks A Benard, Sheree Bailey, Satinder Kaur, Paul Leo, John Toubia, Chloe Thompson-Peach, Tran Nguyen and 17 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 9 institutions in 3 countries.

Mahmoud A Bassal *Harvard Stem Cell Institute, Harvard Medical School, Boston, USA.ORCID http://orcid.org/0000-0003-4322-2968
Saumya E Samaraweera *Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.ORCID http://orcid.org/0000-0002-9619-0624
Kelly LimDiscipline of Medicine, University of Adelaide, Adelaide, Australia.ORCID http://orcid.org/0000-0003-4606-7588
Brooks A BenardHematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University, Stanford, USA.ORCID http://orcid.org/0000-0001-7154-744X
Sheree BaileyClinical and Health Sciences, University of South Australia, Adelaide, Australia.ORCID http://orcid.org/0000-0001-6690-5476
Satinder KaurDiscipline of Medicine, University of Adelaide, Adelaide, Australia.
Paul LeoDiamantina Institute, Translational Research Institute, Brisbane, Australia.
John ToubiaCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.ORCID http://orcid.org/0000-0002-5135-6504
Chloe Thompson-PeachDiscipline of Medicine, University of Adelaide, Adelaide, Australia.ORCID http://orcid.org/0000-0001-7172-3183
Tran NguyenCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.
Kyaw Ze Ya MaungCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.
Debora A CasolariCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.ORCID http://orcid.org/0000-0001-5072-0880
Diana G IarossiCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.
Ilaria S PaganiPrecision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.
Jason PowellCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.
Stuart PitsonCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.ORCID http://orcid.org/0000-0002-9527-2740
Siria NateraMetabolomics Australia, The University of Melbourne, Melbourne, Australia.
Ute RoessnerMetabolomics Australia, The University of Melbourne, Melbourne, Australia.ORCID http://orcid.org/0000-0002-6482-2615
Ian D LewisAdelaide Oncology & Haematology, Adelaide, Australia.
Anna L BrownCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.ORCID http://orcid.org/0000-0002-9023-0138
Daniel G TenenHarvard Stem Cell Institute, Harvard Medical School, Boston, USA.
Nirmal RobinsonCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.ORCID http://orcid.org/0000-0002-7361-9491
David M RossCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.
Ravindra MajetiHematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University, Stanford, USA.ORCID http://orcid.org/0000-0002-5814-0984
Thomas J GondaClinical and Health Sciences, University of South Australia, Adelaide, Australia.
Daniel ThomasDiscipline of Medicine, University of Adelaide, Adelaide, Australia.ORCID http://orcid.org/0000-0002-0837-1231
Richard J D'AndreaCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia. Richard.DAndrea@unisa.edu.au.ORCID http://orcid.org/0000-0002-4915-4612
South Australia Pathology · AUThe University of Adelaide · AUHarvard University · USSouth Australian Health and Medical Research Institute · AUStanford University · USThe University of Melbourne · AUThe University of Queensland · AUTranslational Research Institute · AUUniversity of South Australia · AU

Funding

Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
NCI NIH HHS T32 CA009302
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35840577
PMCPMC9287394
OpenAlexW4285490739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.